Vycor Medical, Inc.
VYCO
$0.0648
-$0.0041-5.95%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.79% | 20.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.79% | 20.56% | |||
| Cost of Revenue | 4.55% | -4.86% | |||
| Gross Profit | -4.58% | 23.70% | |||
| SG&A Expenses | 8.91% | 14.66% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.20% | 12.58% | |||
| Operating Income | -316.67% | 270.53% | |||
| Income Before Tax | -498.00% | 67.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -498.00% | 67.21% | |||
| Earnings from Discontinued Operations | -- | 100.00% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -498.00% | 67.32% | |||
| EBIT | -316.67% | 270.53% | |||
| EBITDA | -160.82% | 422.95% | |||
| EPS Basic | -2,133.33% | 94.92% | |||
| Normalized Basic EPS | -450.00% | 66.67% | |||
| EPS Diluted | -2,133.33% | 94.92% | |||
| Normalized Diluted EPS | -450.00% | 66.67% | |||
| Average Basic Shares Outstanding | 0.84% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.84% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
